STRS Ohio’s KALA BIO KALA Stock Holding History

STRS Ohio’s Portfolio KALA Stock Details KALA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-1	Closed	-$37K	–	2148
2018 Q1	$37K	Hold	1	–	–	﹤0.01%	1772
2017 Q4	$44K	Hold	1	–	–	﹤0.01%	1764
2017 Q3	$54K	Buy	+1	New	+$54.9K	﹤0.01%	1771

Other funds holding KALA

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

TRV GP Boston, Massachusetts $18.9M AUM 541.67% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

STRS Ohio's KALA Position: Q2 2018 in Review

STRS Ohio sold out of KALA BIO (KALA) in Q2 2018, closing a stake of 1 share — an estimated $37K sold.

STRS Ohio first reported a position in KALA in Q3 2017 and held it in 3 quarters. The position peaked at $54K in Q3 2017. 54 funds tracked by Wall St. Rank hold KALA as of Q2 2018.

STRS Ohio reported no remaining KALA BIO position as of Q2 2018 after selling out during the quarter.
STRS Ohio sold 1 KALA BIO share in Q2 2018, an estimated $37K.
STRS Ohio first reported a position in KALA BIO in Q3 2017 and held it in 3 quarters.
STRS Ohio's KALA BIO position peaked at $54K in Q3 2017.
54 funds tracked by Wall St. Rank held KALA BIO as of Q2 2018.

Based on STRS Ohio's 13F filing for Q2 2018, filed 6 Aug 2018.